Rockefeller Capital Management »

Aeglea Biotherapeutics shares owned by Rockefeller Capital Management

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Rockefeller Capital Management from 13F filings

Historical chart of Rockefeller Capital Management investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Rockefeller Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Rockefeller Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $6.7k 401 16.76

More positions owned by Rockefeller Capital Management

Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Apple (AAPL)
NVIDIA Corporation (NVDA)
salesforce (CRM)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Tidal Trust Iii Rockefeller Glob (RGEF)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Tidal Trust Iii Rockefeller Us S (RSMC)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for Rockefeller Capital Management

Top funds holding Aeglea Biotherapeutics

FMR
Fairmount Funds Management
BlackRock
Rtw Investments
Tang Capital Management
Vanguard Group
VR Adviser
Braidwell
Capital Research and Management Company - Division 3
Driehaus Capital Management
Commodore Capital
State Street Corporation
Wellington Management Company
Paradigm Biocapital Advisors
Affinity Asset Advisors

View all funds holding Aeglea Biotherapeutics